Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Prostatic Neoplasms × Injections × Clear all

Status

Sponsor Class

Study Type

Interventional 23 Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uncommon Pathological Types of Lung Cancer 1 Prostatic Neoplasms 1 Liver Neoplasms 1 Liver Cirrhosis 1 Endometrial Neoplasms 1 Chemotherapy-induced Thrombocytopenia 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Surveys and Questionnaires 34 Blood Specimen Collection 24 enzalutamide 18 Docetaxel 15 Radiotherapy 14 Biopsy 14 Abiraterone Acetate 14 apalutamide 13 Leuprolide 13 Interviews as Topic 13 Magnetic Resonance Spectroscopy 12 Observation 11 Watchful Waiting 10 radium Ra 223 dichloride 9 darolutamide 9 Androgen Antagonists 9 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8 Radiosurgery 7 Magnetic Resonance Imaging 7 Brachytherapy 7 abiraterone 6 Specimen Handling 6 Amplified Fragment Length Polymorphism Analysis 6 Triptorelin Pamoate 5 Standard of Care 5 Positron Emission Tomography Computed Tomography 5 Gonadotropin-Releasing Hormone 5 Focus Groups 5 Registries 4 Radiotherapy, Intensity-Modulated 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02238366 2019-07-25

CHRONOS3

Ipsen

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡